Development and Validation of Deep Neural Networks for Blinking Identification and Classification

January 2, 2023 updated by: Georgios Labiris, Democritus University of Thrace
Primary objective of this study is the development and validation of a system of deep neural networks which automatically detects and classifies blinks as "complete" or "incomplete" in image sequences.

Study Overview

Detailed Description

This method is based on iris and sclera segmentation in both eyes from the acquired images, using state of the art deep learning encoder-decoder neural architectures (DLED). The sequence of the segmented frames is post-processed to calculate the distance between the eyelids of each eye (palpebral fissure) and the corresponding iris diameter. Theses quantities are temporally filtered and their fraction is subject to adaptive thresholding to identify blinks and determine their type, independently for each eye. The two DLEDs were trained with manually segmented images and the post-process was parameterized using a 4-minute video. After DLED training, the proposed system was tested on 8 different subjects, each one with a 4-10-minute video. Several metrics of blink detection and classification accuracy were calculated against the ground truth, which was generated by 3 independent experts, whose conflicts were resolved by a senior expert. Two independent blink identifications are assumed to be in agreement, if and only if there is sufficient temporal overlapping and the type of blink is the same between the DLED system and the ground truth.

Study Type

Observational

Enrollment (Actual)

8

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Evros
      • Alexandroupolis, Evros, Greece, 68100
        • Department of Ophthalmology, University Hospital of Alexandroupolis
    • Thessaly
      • Lamia, Thessaly, Greece, 35100
        • Department of Computer Science and Biomedical Informatics, University of Thessaly

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Patients aged from 18 to 75 years with Uncorrected Distance Visual Acuity ≥ 5/10

Description

Inclusion Criteria

  • Uncorrected Distance Visual Acuity above 6/12

Exclusion Criteria:

  • corneal opacities
  • age-related macular degeneration
  • diagnosis of psychiatric diseases
  • former eyelid surgery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Study group
8 patients aged between 18 to 75 years with Uncorrected Distance Visual Acuity ≥ 5/10

Both eyes will be included for each study participant. Participants watched a 4-10-minute video in standard mesopic environmental lighting conditions at 3.5m viewing distance. Simultaneously, all blinking moves will be recorded through a web infrared camera.

The proposed system was tested on the 8 different subjects. Several metrics of blink detection and classification accuracy were calculated against the ground truth, which was generated by 3 independent experts, whose conflicts were resolved by a senior expert. Two independent blink identifications are assumed to be in agreement, if and only if there is sufficient temporal overlapping and the type of blink is the same between the DLED system and the ground truth.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Identification of complete and incomplete blinks
Time Frame: up to 1 week
Complete and incomplete blinks are defined by the "length of palpebral fissure-to-iris diameter" ratio
up to 1 week
First frame of each blink
Time Frame: up to 1 week
The frame in which the upper eyelid starts to move down and cover the cornea
up to 1 week
Last frame of each blink
Time Frame: up to 1 week
The frame in which eyelids open fully after a blink
up to 1 week

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Length of palpebral fissure of both eyes
Time Frame: up to 1 week
The distance between the upper eyelid margin and the lower eyelid margin (ie. the vertical dimension of the palpebral fissure),
up to 1 week
Iris diameter of both eyes
Time Frame: up to 1 week
The horizontal diameter of the iris (ie. the horizontal white-to white distance)
up to 1 week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2020

Primary Completion (Actual)

March 10, 2021

Study Completion (Actual)

March 25, 2021

Study Registration Dates

First Submitted

March 29, 2021

First Submitted That Met QC Criteria

March 31, 2021

First Posted (Actual)

April 1, 2021

Study Record Updates

Last Update Posted (Actual)

January 4, 2023

Last Update Submitted That Met QC Criteria

January 2, 2023

Last Verified

January 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Deep Learning

Clinical Trials on Comparison of the proposed artificial network with the ground truth

Subscribe